Thermo Fisher Scientific Inc (NYSE:TMO) over-valued by 9%
| Website | https://www.thermofisher.com/ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Fiscal Year End | Dec 31, 2019 |
| Market Cap | $173,347,095,000 |
| Beta | 0.98463 |
| Average Volume | $1,287,609 |
| Last Dividend | 0.79% |
| Price on Jul 31, 2020 | $428.39 |
| Autochartist™ Valuation | $390.89 |
| Conclusion |
9% over-valued |
| Download Report |
